united therapeutics corp
(UTHR:Consolidated Issue Listed on NASDAQ Global Select )
Director, Chairman of Audit Committee and Member of Nominating & Governance Committee, United Therapeutics Corporation
|Age||Total Calculated Compensation||This person is connected to 12 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Mr. Richard Giltner served as the Managing Director of Societe Generale Asset Management until October 15, 2008 and as Head of the European Office for its fund of hedge funds group since 2006. From 2003 to 2006, Mr. Giltner was the Global Head of Foreign Exchange options for the investment banking arm of Societe Generale. He has been a Director at United Therapeutics Corporation since April 2009. He has over twenty years of experience in the financial sector. His areas ...
1040 Spring StreetPhone: 301-608-9292
Silver Spring, Maryland 20910
Board Members Memberships*
Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Jean-Paul Clozel M.D.||Founder, Chief Executive Officer, Member of Management Board and Director|
|David L. Hallal||Chief Executive Officer and Director|
Alexion Pharmaceuticals, Inc.
|Mark C. Rohr||Chairman of the Board, Chief Executive Officer and President|
|Shigenobu Maekawa||President and Representative Director|
Nippon Shinyaku Co. Ltd.
|--||Compensation as of Fiscal Year 2014.|